Infosys partners to offer paperless validation system to pharma, biotech industry

Infosys said that it has partnered with paperless validation company ValGenesis to bring stronger compliance and quality management for its customers in the healthcare and life sciences sectors

Must Read

Explained: The evolving nature of cybersecurity threats

Concerns such as hacking and the presence of computer viruses have existed for decades in one form or another. As technology evolved over the years, so did the cybersecurity  threats themselves.

Sapience Analytics signs distribution agreement with Redington

Sapience Analytics and Redington said that they have entered into a distribution agreement where latter will resell the Sapience Vue solution through its network of over 30,000 channel partners, system integrators, and value-added resellers countrywide.

Andhra Pradesh to resurvey and digitise all land records

The push for resurvey and of land records in Andhra Pradesh comes from the success of resurvey done in Thakkellapadu of Jaggayyapeta mandal in Krishna district

Indian IT major said that it has partnered with paperless validation company to bring stronger compliance and quality management for its customers in the healthcare and life sciences sectors. Under the partnership, Infosys will integrate Validation Lifecycle Management System (VLMS) within its suite of services for the pharmaceutical and biotech industry, which will be delivered in a cloud environment.

ValGenesis is a paperless validation lifecycle management solution in the life sciences industry that allows customers to automate the validation process fully, eliminate inefficiencies found in paper-based manual processes, while also reducing costs and validation cycle times. The ValGenesis Validation Lifecycle Management System (VLMS) manages all types of validation activities such as equipment, computer systems, cleaning, analytical methods, and process validation.

Infosys said that validation systems are still almost entirely manual, paper-based process, resulting in significant inefficiencies, higher costs and more significant opportunity for errors to creep in. They can also result in delays to life-saving medicines and procedures to patients. ValGenesis’ VLMS includes a regulatory framework allowing validation requirements to be specified in advance. Risk Management, a key component of VLMS, is integrated and flexible, giving companies the ability to leverage standard risk tools to best suit their needs.

Indian IT major informs that its Life Sciences Practice works with over 50 leading pharmaceutical and medical devices companies, providing premium regulatory, quality and compliance services. Leveraging its extensive capabilities and experience in the life sciences space, Infosys will deploy the ValGenesis Validation Lifecycle Management System (VLMS) to its customers as a single “paperless” system that manages every activity in the entire validation lifecycle. Through this partnership, Infosys will help biopharma and medical devices customers to automate their processes.

“Healthcare is potentially the world’s most stringently-regulated industry. The huge volumes of highly-sensitive information that biotech and life sciences firms generate is subject to incredibly strict standards – for example, recording the outcomes from clinical trials. The digitization of the industry to ensure better data and document accuracy is incredibly important for many ethical, legal and business reasons, with auditors and regulators demanding that data regarding equipment, computer systems, processes, and outcomes be properly recorded and validated. ValGenesis is pioneering paperless validation, and our new partnership will bring significant savings and much better compliance to our customers,” said Sangita Singh, Executive Vice President and Head, Healthcare & Lifesciences, Infosys.

“Infosys’ long pedigree in life sciences makes them the perfect partner for ValGenesis as we seek to transform validation for the life sciences and biomedical sectors. Infosys has a comprehensive understanding of the pressures faced by these firms, such as the demand for reducing costs, optimising efficiency, and ensuring that they meet the most stringent regulatory requirements. We look forward to a long and fruitful partnership, with ValGenesis’ technology complementing Infosys’ product set to redefine the way that biopharma firms conduct their business, optimising patient safety, and helping to bring new treatments to the public as quickly and safely as possible,” said Narayan Raj, VP Sales at ValGenesis.

Subscribe to receive the day's headlines from Tech Observer straight in your inbox

Leave a Reply

*The moderation of comments is automated and not cleared manually by techobserver.in. Embedding of any link and use of abusive or unparliamentary language are prohibited.
- Advertisement -

Latest in TECH

Sapience Analytics signs distribution agreement with Redington

Sapience Analytics and Redington said that they have entered into a distribution agreement where latter will resell the Sapience Vue solution through its network of over 30,000 channel partners, system integrators, and value-added resellers countrywide.
- Advertisement -SAP Hana

Related Articles